staurosporine has been researched along with Parkinson Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arena, G; Brunelli, F; Franzone, D; Gelmetti, V; Grünewald, A; Krüger, R; Torosantucci, L; Valente, EM | 1 |
| Arndt-Jovin, DJ; Falomir-Lockhart, LJ; Flierl, A; Hesley, J; Jaenisch, R; Jovin, TM; Langston, JW; Mak, SK; Oliveira, LM; Schüle, B; Soldner, F | 1 |
| Chen, CM; Chen, IC; Fung, HC; Huang, SY; Kao, SH; Lee, GC; Lee-Chen, GJ; Soong, BW; Wu, YR | 1 |
| Sen, S; Webber, PJ; West, AB | 1 |
| Amadoro, G; Atlante, A; Bussani, R; Calissano, P; Capsoni, S; Corsetti, V; Florenzano, F; Mercanti, D | 1 |
| Gu, L; Sun, L; Wang, S; Yang, H; Yuan, J; Zhang, H; Zhu, J | 1 |
| Berger, K; Cookson, MR; Eberhardt, O; Engelender, S; Farrer, MJ; Gerhardt, E; Hernandez, D; Holzmann, C; Kachergus, J; Krüger, R; Li, L; Marx, FP; Riess, O; Ross, CA; Schöls, L; Schulz, JB; Strauss, KM | 1 |
| Davidson, SM; Jensen, PH; Kahns, S; Latchman, DS; MacCormac, LP; Muqit, MM; Payne Smith, MD; Wood, NW | 1 |
| Danion, JM; de Barry, J; Janoshazi, A; Marescaux, C; Sellal, F; Warter, JM | 1 |
| Chang, II; Choi, EJ; Choi, WS; Jin, BK; Krajewski, S; Oh, TH; Oh, YJ; Reed, JC; Rhim, H; Yoon, SY | 1 |
| Ancolio, K; Checler, F; da Costa, CA | 1 |
| Ambrosio, S; Barrachina, M; Ferrer, I; Gómez-Santos, C; Reiriz, J; Viñals, F | 1 |
12 other study(ies) available for staurosporine and Parkinson Disease
| Article | Year |
|---|---|
PINK1 Protects against Staurosporine-Induced Apoptosis by Interacting with Beclin1 and Impairing Its Pro-Apoptotic Cleavage.
Topics: Apoptosis; Beclin-1; Humans; Parkinson Disease; Protein Kinases; Staurosporine | 2022 |
Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
Topics: alpha-Synuclein; Apoptosis; Cell Differentiation; Cell Survival; Cells, Cultured; Cellular Senescence; Culture Media; Energy Metabolism; Female; Gene Duplication; Gene Expression Regulation; Glucose; Humans; Hydrogen Peroxide; Induced Pluripotent Stem Cells; Male; Membrane Potential, Mitochondrial; Mitochondria; Neural Stem Cells; Parkinson Disease; RNA, Small Interfering; Staurosporine; Substantia Nigra | 2014 |
SCA8 repeat expansion: large CTA/CTG repeat alleles in neurological disorders and functional implications.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Base Sequence; Case-Control Studies; Cell Line; Central Nervous System Diseases; DNA Primers; Female; Gene Expression; Humans; Leupeptins; Lymphocytes; Male; Microfilament Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Parkinsonian Disorders; Polymorphism, Single Nucleotide; Pyrimidines; RNA, Long Noncoding; RNA, Untranslated; Spinocerebellar Ataxias; Staurosporine; Sulfonamides; Trinucleotide Repeat Expansion | 2009 |
Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization.
Topics: Amino Acid Substitution; Cell Line; Enzyme Activation; Enzyme Inhibitors; Guanosine Triphosphate; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mutation, Missense; Parkinson Disease; Protein Multimerization; Protein Serine-Threonine Kinases; Protein Structure, Quaternary; Protein Structure, Tertiary; Staurosporine | 2009 |
Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
Topics: Adenine Nucleotide Translocator 1; Adenosine Diphosphate; Adenosine Triphosphate; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Apoptosis; Brain; Cells, Cultured; Cerebellum; Cyclophilins; Disks Large Homolog 4 Protein; Enzyme Inhibitors; Female; Humans; Immunoprecipitation; Intracellular Signaling Peptides and Proteins; Lewy Body Disease; Male; Membrane Proteins; Middle Aged; Mitochondria; Neuroblastoma; Neurons; Parkinson Disease; Peptide Fragments; Rats; Rats, Wistar; Receptors, AMPA; Staurosporine; Subcellular Fractions; Synapses; Synaptosomes; tau Proteins | 2012 |
N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity.
Topics: Acetylcysteine; Animals; Apoptosis; Cell Line; Cell Survival; Disease Models, Animal; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Free Radical Scavengers; Methoxyhydroxyphenylglycol; Oxidation-Reduction; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Metabotropic Glutamate; Staurosporine | 2012 |
Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease.
Topics: Acetylcysteine; Adult; Aged; alpha-Synuclein; Amino Acid Sequence; Carrier Proteins; Case-Control Studies; Cell Death; Cells, Cultured; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Female; Green Fluorescent Proteins; Humans; Luminescent Proteins; Male; Middle Aged; Molecular Sequence Data; Multienzyme Complexes; Mutation; Nerve Tissue Proteins; Neurons; Parkinson Disease; Proteasome Endopeptidase Complex; Recombinant Fusion Proteins; Staurosporine; Synucleins; Ubiquitin-Protein Ligases | 2003 |
Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival.
Topics: Blotting, Western; Cell Survival; Dopamine; Gene Expression Regulation; Humans; Inclusion Bodies; Leupeptins; Microscopy, Fluorescence; Microtubule-Organizing Center; Parkinson Disease; Staurosporine; Tubulin; Tumor Cells, Cultured; Ubiquitin; Ubiquitin-Protein Ligases; Vimentin | 2004 |
Alteration of protein kinase C conformation in red blood cells: a potential marker for Alzheimer's disease but not for Parkinson's disease.
Topics: Age Factors; Aged; Alzheimer Disease; Analysis of Variance; Biomarkers; Enzyme Inhibitors; Erythrocytes; Female; Fluoresceins; Humans; Indoles; Male; Parkinson Disease; Phorbol Esters; Protein Conformation; Protein Kinase C; Spectrum Analysis; Staurosporine | 2006 |
Correlation between structure of Bcl-2 and its inhibitory function of JNK and caspase activity in dopaminergic neuronal apoptosis.
Topics: Apoptosis; Caspases; Cells, Cultured; Dopamine; Enzyme Inhibitors; Humans; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Mutation; Neurons; Parkinson Disease; Protein Structure, Tertiary; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Structure-Activity Relationship; Transfection | 2000 |
Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli.
Topics: Adult; alpha-Synuclein; Apoptosis; Caspases; Ceramides; Cysteine Proteinase Inhibitors; Etoposide; Humans; Mutation; Neocortex; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Parkinson Disease; Staurosporine; Synucleins; Transfection | 2000 |
MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Brain; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Neuroblastoma; Neurons; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphorylation; Staurosporine; Synucleins; Tumor Cells, Cultured; Up-Regulation | 2002 |